Publication

Development of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genes

Downloadable Content

Persistent URL
Last modified
  • 02/20/2025
Type of Material
Authors
    Christopher C. Stobart, Emory UniversityMartin Moore, Emory University
Language
  • English
Date
  • 2015-12-02
Publisher
  • Expert Reviews (formerly Future Drugs)
Publication Version
Copyright Statement
  • © 2015 Taylor & Francis.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1476-0584
Volume
  • 14
Issue
  • 12
Start Page
  • 1563
End Page
  • 1572
Grant/Funding Information
  • This work was supported by NIH grants R01AI087798 (MLM), U19 AI095227 (MLM), and T32 AI074492 (CCS) and the Emory Children’s Center for Childhood Infections and Vaccines (CCIV).
Abstract
  • Vaccines represent one of the greatest contributions of the scientific community to global health. Yet, many pathogens remain either unchallenged or inadequately hindered by commercially available vaccines. Respiratory viruses pose distinct and difficult challenges due to their ability to rapidly spread, adapt, and modify the host immune response. Considerable research has been directed to understand the role of respiratory virus immunomodulatory proteins and how they influence the host immune response. We review here efforts to develop next-generation vaccines through targeting these key immunomodulatory genes in influenza virus, coronaviruses, respiratory syncytial virus, measles virus, and mumps virus.
Author Notes
  • Author to whom correspondence should be addressed: Martin Moore; Email: martin.moore@emory.edu (Tel: 404-727-9162/Fax: 404-727-9223)
Keywords
Research Categories
  • Health Sciences, Immunology
  • Biology, Virology

Tools

Relations

In Collection:

Items